p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14612499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pifithrin-α supresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis

  2003cited by this paper
• A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors

  2003cited by this paper
• Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis.

  2003cited by this paper
• AKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1

  2003cited by this paper
• Activation of Akt is essential for acetylcholine to trigger generation of oxygen free radicals.

  2003cited by this paper
• Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer

  2003cited by this paper
• Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.

  2002cited by this paper
• Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells.

  2002cited by this paper
• Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53*

  2002cited by this paper
• Involvement of inhibitory nuclear factor-kappaB (NFkappaB)-independent NFkappaB activation in the gonadotropic regulation of X-linked inhibitor of apoptosis expression during ovarian follicular development in vitro.

  2002cited by this paper
• Suppression of Akt Signaling Induces Fas Ligand Expression: Involvement of Caspase and Jun Kinase Activation in Akt-Mediated Fas Ligand Regulation

  2002cited by this paper
• Involvement of Inhibitory Nuclear Factor-κB (NFκB)-Independent NFκB Activation in the Gonadotropic Regulation of X-Linked Inhibitor of Apoptosis Expression during Ovarian Follicular Development in Vitro.

  2002cited by this paper
• Human Ovarian Cancer and Cisplatin Resistance: Possible Role of Inhibitor of Apoptosis Proteins* * This work was supported by grants from the Canadian Institutes of Health Research (MOP-15691), the University of Ottawa-Industry Grants Program, and the Ottawa Civic Hospital Foundation.

  2001influential reference
• Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins.

  2001cited by this paper
• c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.

  2001cited by this paper
• XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.

  2001influential reference
• The Akt Proto-oncogene Links Ras to Pak and Cell Survival Signals*

  2000cited by this paper
• Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.

  2000influential reference
• Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli.

  2000cited by this paper
• Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer

  2000cited by this paper
• The Phosphoinositide 3-OH Kinase/AKT2 Pathway as a Critical Target for Farnesyltransferase Inhibitor-Induced Apoptosis

  2000cited by this paper
• Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

  1999cited by this paper
• A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

  1999cited by this paper
• Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells

  1999cited by this paper
• Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

  1999cited by this paper
• Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• X-linked IAP is a direct inhibitor of cell-death proteases

  1997cited by this paper
• P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.

  1996cited by this paper
• AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

  1992cited by this paper

• Targeted Accumulation of Reactive Acrolein via Nanoparticle-embedded Reverse Temperature Hydrogel for Bladder Cancer Treatment

  2026cites this paper
• The flavonoid hyperoside attenuates the toxic effect of cisplatin on the human ovarian granulosa cells: in vitro model study

  2025cites this paper
• Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance

  2025cites this paper
• Histone acetylation: a key determinant of acquired cisplatin resistance in cancer

  2024cites this paper
• Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat.

  2023cites this paper
• Collagen XI Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment

  2022cites this paper
• PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells

  2022cites this paper
• The Prognostic Significance of the Signaling Proteins: PTEN, P85α, ATM and XIAP in Primary Ovarian Cancer

  2021cites this paper
• Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells

  2021cites this paper
• Chemoresistance in uterine cancer: Mechanisms of resistance and current therapies

  2021cites this paper
• Long Non-Coding RNA (lncRNA) BMP/OP-Responsive Gene (BORG) Promotes Development of Chemoresistance of Colorectal Cancer Cells to Carboplatin

  2020cites this paper
• Postpartum breast cancer progression is driven by semaphorin 7a mediated invasion and survival

  2020cites this paper
• PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers

  2020cites this paper
• The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance

  2019cites this paper
• TGF-β1 protects colon tumor cells from apoptosis through XAF1 suppression.

  2019cites this paper
• Molecular and Cellular Basis of Chemoresistance in Ovarian Cancer

  2019cites this paper
• Crosstalk between Phosphoinositide 3‐kinase/Akt signaling pathway with DNA damage response and oxidative stress in cancer

  2019cites this paper
• Alpha7 nAChR Expression Is Correlated with Arthritis Development and Inhibited by Sinomenine in Adjuvant-Induced Arthritic Rats

  2019cites this paper
• p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling

  2019cites this paper
• Semaphorin 7a promotes breast tumor progression via cell survival, matrix remodeling, and epithelial to mesenchymal transition

  2019cites this paper
• Deubiquitinating enzyme 4 facilitates chemoresistance in glioblastoma by inhibiting P53 activity

  2018cites this paper
• Antiproliferative effects of the CDK6 inhibitor PD0332991 and its effect on signaling networks in gastric cancer cells

  2018cites this paper
• Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.

  2018cites this paper
• Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer

  2018cites this paper
• S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53.

  2018cites this paper
• Mifepristone is a valuable therapeutic alternative in oncology

  2018cites this paper
• Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro.

  2017cites this paper
• 11 Antiprogestins in Ovarian Cancer

  2017cites this paper
• An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.

  2017cites this paper
• p 53 is essential for embelin-induced apoptosis in p 53-wildtype prostate cancer cells

  2016cites this paper
• Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest.

  2016cites this paper
• Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer

  2016cites this paper
• Chemoresistance and targeted therapies in ovarian and endometrial cancers

  2016influential citation
• Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780/Taxol to paclitaxel in xenografted tumor in nude mice

  2016cites this paper
• Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner

  2015cites this paper
• The Flavonoid Apigenin Ameliorates Cisplatin-Induced Nephrotoxicity through Reduction of p53 Activation and Promotion of PI3K/Akt Pathway in Human Renal Proximal Tubular Epithelial Cells

  2015cites this paper
• Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death

  2015cites this paper
• Oncogenes associated with drug resistance in ovarian cancer

  2015cites this paper
• COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization

  2015cites this paper
• Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability

  2015cites this paper
• Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma

  2015cites this paper
• Adenovirus type 12 E1B 55-kilodalton oncoprotein promotes p53-mediated apoptotic response of ovarian cancer to cisplatin

  2015cites this paper
• Molecular Mechanisms of Therapeutic Resistance in Cancer.

  2015cites this paper
• “Ziziphus jujuba”: A red fruit with promising anticancer activities

  2015cites this paper
• THE ROLE AND REGULATION of MITOCHONDRIAL DYNAMICS IN CISPLATIN RESISTANCE IN HUMAN GYNECOLOGIC CANCER CELLS

  2015cites this paper
• SIAH1-induced p34SEI-1 polyubiquitination/degradation mediates p53 preferential vitamin C cytotoxicity.

  2015cites this paper
• Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.

  2015cites this paper
• Effect of Smac and Taxol on non-small-cell lung cancer.

  2014cites this paper
• Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine

  2014cites this paper
• Gelsolin regulates cisplatin sensitivity in human head‐and‐neck cancer

  2014cites this paper
• The Role and Regulation of the Phosphatase PPM1D in Chemoresistant Gynecological Cancers

  2014cites this paper
• p53 Is Required for Cisplatin-induced Processing of the Mitochondrial Fusion Protein L-Opa1 That Is Mediated by the Mitochondrial Metallopeptidase Oma1 in Gynecologic Cancers*

  2014cites this paper
• X-linked inhibitor of apoptosis-associated factor l (XAFl) enhances the sensitivity of colorectal cancer cells to cisplatin

  2014cites this paper
• Downregulation of HNF1 homeobox B is associated with drug resistance in ovarian cancer.

  2014cites this paper
• Cell fate regulation by gelsolin in human gynecologic cancers

  2014cites this paper
• Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis

  2014cites this paper
• DHA2, a synthesized derivative of bisbibenzyl, exerts antitumor activity against ovarian cancer through inhibition of XIAP and Akt/mTOR pathway.

  2014cites this paper
• Mifepristone : A prototypical antiprogestin

  2014cites this paper
• Radiosensitizing activity of a novel Benzoxazine through the promotion of apoptosis and inhibition of DNA repair

  2014cites this paper
• Inhibition of PI3K/Akt/mTOR signaling pathway enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin in vitro.

  2014cites this paper
• Downregulation of HNF 1 homeobox B is associated with drug resistance in ovarian cancer

  2014cites this paper
• Importance of EGFR/ERCC1 Interaction Following Radiation-Induced DNA Damage

  2014cites this paper
• Cancer Therapy : Preclinical ImportanceofEGFR / ERCC 1 InteractionFollowingRadiation-Induced DNA Damage

  2014cites this paper
• The interaction between C35 and ΔNp73 promotes chemo-resistance in ovarian cancer cells

  2013cites this paper
• SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro

  2013cites this paper
• Regulation of AKT gene expression by cisplatin

  2013cites this paper
• New Perspectives in Chemoresistant Ovarian Cancer

  2013cites this paper
• The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells

  2013cites this paper
• Effect of chemotherapy with cisplatin and rapamycin on HeLa cells in vitro

  2013cites this paper
• Characterization of disease progression in ovarian cancer by utilizing ‘chemograms’ of ovarian cancer stem cells

  2013cites this paper
• Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.

  2013cites this paper
• VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia

  2013cites this paper
• Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation

  2013cites this paper
• Modeling of Cancer Signaling Pathways

  2013cites this paper
• Effect of combination of rapamycin and cisplatin on human cervical carcinoma Hela cells

  2013cites this paper
• Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents.

  2013cites this paper
• Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation.

  2013cites this paper
• Metabolic and mitochondrial remodelling in cisplatin resistance: studies on ovarian cancer cells and derived cytoplasmic hybrids

  2013cites this paper
• Tumor suppressor genes associated with drug resistance in ovarian cancer (review).

  2013cites this paper
• PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation

  2013influential citation
• Protein Kinase G-Iα Hyperactivation and VASP Phosphorylation in Promoting Ovarian Cancer Cell Migration and Platinum Resistance

  2013cites this paper
• 13-Methyltetradecanoic Acid Exhibits Anti-Tumor Activity on T-Cell Lymphomas In Vitro and In Vivo by Down-Regulating p-AKT and Activating Caspase-3

  2013cites this paper
• Cells, Stem Cells, and Cancer Stem Cells

  2013cites this paper
• A Small Molecule SMAC Mimic LBW242 Potentiates TRAIL- and Anticancer Drug-Mediated Cell Death of Ovarian Cancer Cells

  2012cites this paper
• Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma

  2012cites this paper
• Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum

  2012cites this paper
• Anti‐miR‐155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis

  2012cites this paper
• Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer.

  2012cites this paper
• In search of new prognostic molecular markers in ovarian cancer

  2012cites this paper
• DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer

  2012cites this paper
• Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML)

  2012cites this paper
• Positron Emission Tomography Imaging of Platinum Resistant Ovarian Cancer And Drug Modulation

  2012cites this paper
• Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells.

  2012influential citation
• Ovarian cancer stem cells: elusive targets for chemotherapy

  2012cites this paper
• Epithelial Ovarian Cancer – Adjuvant Measures with Potential for Slowing Its Spread and Boosting or Restoring its Chemosensitivity

  2012cites this paper
• Hox Gene Expression in Ovarian Cancer

  2012cites this paper
• Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma

  2012cites this paper
• OGDHL Is a Modifier of AKT-Dependent Signaling and NF-κB Function

  2012cites this paper
• On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy

  2012cites this paper
• Antiprogestins in Ovarian Cancer

  2012cites this paper